Delivery Order SPE2DB20D1100-SPE2DB25FE6J1
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,760.99 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count). The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $8,166.54 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 20 mg capsules (100 count). This firm fixed-price delivery order, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, was competitively awarded without set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $7,920.33. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) valued at $5,911.41. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.11 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (100-count units). The award was made on September 3, 2025, under firm fixed pricing with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded delivery order will be performed at the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The...
- The Defense Logistics Agency awarded a $3,943.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 20 mg, with an ultimate completion date of August 18, 2025. This non-set-aside contract represents a pharmaceutical supply delivery executed through the company's established federal procurement relationship. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) with a contract ceiling value of $1,339.45. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is located at the contractor's corporate office in Conshohocken, PA, with an...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.66 to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units). The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This award was made through open competition with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,418.06 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units). This is a non-set-aside competitive award with a completion date of September 10, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6J1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,044.69 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (90-count units) under a firm fixed price contract type. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. The company's performance under such contracts demonstrates its capability to fulfill federal medical supply requirements through open competition and maintain consistent delivery of critical medications and healthcare commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 9/12/25 |